BIOVASCULAR

biovascular-logo

BioVascular is a clinical stage privately held biotechnology company developing “first in class” products for platelet mediated cardiovascular diseases. BioVascular’s initial product, saratin, is a polypeptide produced by recombinant means in yeast. This product was discovered by and licensed from Merck KGaA. BioVascular is conducting human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.

#People #Financial #Website #More

BIOVASCULAR

Industry:
Biotechnology Health Diagnostics Medical

Founded:
2006-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.biovascularinc.com

Total Employee:
1+

Status:
Active

Contact:
858-455-5000

Email Addresses:
[email protected]

Total Funding:
10.87 M USD

Technology used in webpage:
Nginx GoDaddy SSL Shockwave Flash Embed Nginx 1.16 Intermedia Media Temple MediaTemple DNS



Current Advisors List

martin-münchbach_image

Martin Münchbach Board of Directors @ BioVascular
Board_member

Investors List

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Series C - BioVascular

domain-associates_image

Domain Associates

Domain Associates investment in Series C - BioVascular

merck-kgaa_image

Merck

Merck investment in Series C - BioVascular

Official Site Inspections

http://www.biovascularinc.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioVascular"

BioVascular - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 858-455-5000 BioVascular is a clinical stage privately held biotechnology company …See details»

BioVascular 2025 Company Profile: Valuation, Funding …

Information on valuation, funding, cap tables, investors, and executives for BioVascular. Use the PitchBook Platform to explore the full profile.See details»

BioVascular - Overview, News & Similar companies - ZoomInfo

BioVascular contact info: Phone number: (858) 455-5000 Website: www.biovascularinc.com What does BioVascular do? BioVascular Inc. is a privately held biotechnology company that …See details»

BioVascular Inc - Company Profile and News - Bloomberg Markets

Company profile page for BioVascular Inc including stock price, company news, executives, board members, and contact informationSee details»

BioVascular Inc Overview | SignalHire Company Profile

Organization Website: biovascularinc.com : Social Links: Phone Number: 858-455-5000: BioVascular Inc industries Pharma: BioVascular Inc Employees Size 1-10 employees: DMA …See details»

BioVascular Inc overview - services, products, equipment data and …

Biovascularinc.com. San Diego, California, United States (858) 455-5000 [email protected] linkedin. BioVascular Inc. BioVascular is a clinical stage privately held biotechnology company …See details»

BioVascular, Inc. - VentureRadar

Novel cardiovascular therapeutics ... Find out more about BioVascular, Inc., Biotechnology, Healthtech and Life Sciences, DNA, RNA, Peptide Therapies and .See details»

www.biovascularinc.com

Www.biovascularinc.comSee details»

Bio-Vascular, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Bio-Vascular, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

BioVascular, Inc.:Company Profile & Technical …

Discovery Company profile page for BioVascular, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

Biovascular - Products, Competitors, Financials, Employees ...

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™) Sep 19, 2024 - New U.S. patent covers the design and composition of the BVP - - Positive results from …See details»

BioVascular, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore BioVascular, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:BVI-007, Saratin.See details»

Biovascular Inc. - BioCentury Company Profiles - BCIQ

Oct 15, 2007 Biovascular Inc. - BioCentury Company Profiles for the biopharma industrySee details»

BioVascular Inc Overview - Salary.com

Discover essential details about BioVascular Inc, including address, contact, and journey of our company's evolution.See details»

Biovascular Inc - Company Info, Employees & Competitors

View Biovascular inc biovascularinc.com location in Usa, revenue, industry and description. Find related and similar companies as well as employees by title and much more. Platform. DATA …See details»

BIO VASCULAR INC - SAINT PAUL, MN - Company Information

BIO VASCULAR INC B. BIO VASCULAR INC CLAIM THIS BUSINESS. 2575 UNIVERSITY AVE W # 180 SAINT PAUL, MN 55114 Get Directions (651) 603-3700. Business Info. Founded …See details»

BioVascular Inc. :: Scrip

Oct 1, 2007 BioVascular is a beneficiary of Merck KGAA's incubator program. launched to encourage start-up companies to develop Merck's shelved technologies. BioVascular gained …See details»

BioVascular, Inc. Merges with Revitus and Acquires First-In

SAN DIEGO, Sept. 10 /PRNewswire/ -- BioVascular, Inc., a company focused on developing therapies targeting platelet-mediated diseases, today announced that it has merged with …See details»

BioVascular-动脉网 - vbdata.cn

[email protected] BioVascular开发并商业化用于控制血小板介导的心血管疾病的药物和装置。 公司致力于成为领先的综合性专业心血管治疗公司,并在具有复杂营销障碍或组合技术 …See details»

BioVascular Inc. Closes $10.87 Million Series C Financing

Feb 8, 2008 BioVascular Inc. Closes $10.87 Million Series C Financing SAN DIEGO, Feb. 7 -- BioVascular Inc., a company focused on developing therapies targeting platelet-mediated …See details»

linkstock.net © 2022. All rights reserved